Gene therapy treats "bubble boy disease," but raises leukemia risk

07/21/2010 | Reuters

A 10-year study showed that eight of nine boys with "bubble boy disease," or X-linked severe combined immunodeficiency disease, a rare ailment that keeps the body from developing mature T cells to ward off infections, were able to live normally after undergoing gene therapy. However, four of nine patients developed T-cell acute leukemia after receiving treatment. Three survived while one died.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY